Neurotech Artificial Intelligence Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
350
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Neurotech Artificial Intelligence General Information
Description
Developer of a data management platform designed to support decision-making and business development. The company's platform utilizes artificial intelligence for high analytical capacity, develops data processing speed, provides proper data security, locates and finds proper data and also assists in data processing, enabling clients to make proper decisions to develop their businesses.
Contact Information
Website
www.neurotech.com.br(Operating Subsidiary)
Corporate Office
- Av. das Nações Unidas, Cj. 145-147
- Torre Alpha Várzea de Baixo
- Sao PauloSao Paulo, 17007
- Brazil
Corporate Office
- Av. das Nações Unidas, Cj. 145-147
- Torre Alpha Várzea de Baixo
- Sao PauloSao Paulo, 17007
- Brazil
Neurotech Artificial Intelligence Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Neurotech Artificial Intelligence Comparisons
Industry
Financing
Details
Neurotech Artificial Intelligence Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RIO analytics | Accelerator/Incubator Backed | Rio de Janeiro, Brazil |
Neurotech Artificial Intelligence Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Neurotech Artificial Intelligence Patents
Neurotech Artificial Intelligence Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2002257857-A1 | Association of a tumor antigen and a system for delivering a cytokine or a chemokine for cancer immunotherapy purposes | Inactive | 03-Apr-2001 | ||
| FR-2822707-A1 | Combination of a tumor antigen and a cytokine or chemokine delivery system for cancer immunotherapy | Inactive | 03-Apr-2001 | ||
| FR-2810046-B1 | Process for conditional immortalization of cells and protein constructions for its implementation | Inactive | 07-Jun-2000 | ||
| AU-2001267612-A1 | Method for conditionally immortalising cells and protein constructs therefor | Inactive | 07-Jun-2000 | ||
| FR-2810046-A1 | Preparing conditionally immortalized cells, useful e.g. for cellular therapy and screening, by treatment with immortalizing proteins | Active | 07-Jun-2000 | C12N15/62 |
Neurotech Artificial Intelligence Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| Domingos Monteiro | Chief Executive Officer, President & Founding Partner | |
| Rafael Nakamoto | Chief Financial Officer & Partner | |
| Adrian Arnaud | Chief Technology Officer |
Neurotech Artificial Intelligence Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Neurotech Artificial Intelligence Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Neurotech Artificial Intelligence FAQs
-
When was Neurotech Artificial Intelligence founded?
Neurotech Artificial Intelligence was founded in 2000.
-
Who is the founder of Neurotech Artificial Intelligence?
Germano Vasconcelos is the founder of Neurotech Artificial Intelligence.
-
Who is the CEO of Neurotech Artificial Intelligence?
Domingos Monteiro is the CEO of Neurotech Artificial Intelligence.
-
Where is Neurotech Artificial Intelligence headquartered?
Neurotech Artificial Intelligence is headquartered in Sao PauloSao Paulo, Brazil.
-
What is the size of Neurotech Artificial Intelligence?
Neurotech Artificial Intelligence has 350 total employees.
-
What industry is Neurotech Artificial Intelligence in?
Neurotech Artificial Intelligence’s primary industry is Business/Productivity Software.
-
Is Neurotech Artificial Intelligence a private or public company?
Neurotech Artificial Intelligence is a Private company.
-
What is the current valuation of Neurotech Artificial Intelligence?
The current valuation of Neurotech Artificial Intelligence is .
-
What is Neurotech Artificial Intelligence’s current revenue?
The current revenue for Neurotech Artificial Intelligence is .
-
Who are Neurotech Artificial Intelligence’s investors?
BoostLAB and TMG Capital have invested in Neurotech Artificial Intelligence.
-
Who are Neurotech Artificial Intelligence’s competitors?
RIO analytics is a competitor of Neurotech Artificial Intelligence.
-
When was Neurotech Artificial Intelligence acquired?
Neurotech Artificial Intelligence was acquired on 09-Nov-2022.
-
Who acquired Neurotech Artificial Intelligence?
Neurotech Artificial Intelligence was acquired by B3(Brazil).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
